Review
Open access
Sep 2026
Hormonal target validation based on biochemical shifts in gender-affirming hormone therapy.
BACKGROUND Hormonal targets for gender-affirming hormone therapy (GAHT) remain largely unvalidated in gender-diverse individuals, with no clinical markers to assess dosing adequacy. We hypothesize that a biochemical shift towards the hormonal profile of the identified sex correlates with appropriate dosing. METHODS A...
Jeroen Vervalcke, L. Marinelli, D. Glintborg et al.
· HORMONES · 0 citations